家庭醫業 評估工具. 65 Beer's Criteria 19.1% i m p l i c i t prescribing indicators Akazawa M (1.68 ) (Medication Appropriateness Index, MAI)
|
|
- Derek Nelson
- 5 years ago
- Views:
Transcription
1 前言 Beer's Criteria 19.1% 2001 Akazawa M (1.68 ) ( 33%) 高雄榮民總醫院家庭醫學部 potentially inappropriate medication; STOPP; START 評估工具 i m p l i c i t prescribing indicators (Medication Appropriateness Index, MAI) 370 家庭醫學與基層醫療 第九期
2 e x p l i c i t prescribing indicators McLeod Canadian Criteria (Defining inappropriate p r a c t i c e s i n p r e s c r i b i n g f o r e l d e r l y people) Beer's ( B e e r ' s C r i t e r i a ), S T O P P ( S c r e e n i n g To o l o f O l d e r P e o p l e ' s Potentially Inappropriate Prescriptions), START (Screening Tool to Alert Doctors to the Right Treatment for Older People) Beer's Criteria, McLeod Canadian Criteria, STOPP, START Beer's Criteria Beer's Criteria Beer's Criteria McLeod Canadian Criteria 1997 McLeod (8 ) (12 ) (11 ) (7 ) Implicit and explicit criteria 1997 r e s e r p i n e - blockers COPD McLeod Canadian criteria STOPP 準則 2007 STOPP 18 ( ) Delphi method 65 STOPP 家庭醫學與基層醫療 第九期 371
3 STOPP # Beer's Criteria A µg digoxin ( ). 2. ( )# 3. ( ). 4. thiazide ( )# 5. -blocker ( ). 6. -blocker verapamil ( ). 7. NYHA Class III or IV diltiazem or verapamil ( ). 8. ( ). 9. aspirin warfarin histamine H 2 receptor antagonist (cimetidine warfarin ) or proton pump inhibitor(ppi) ( ). 10. dipyridamole ( ). 11. aspirin histamine H2 receptor antagonist or PPI ( ). 12.aspirin > 150mg ( ). 13. aspirin ( ). 14. aspirin ( )# 15. warfarin 6 ( ). 16. warfarin 12 ( ). 17. aspirin, clopidogrel, dipyridamole or warfarin ( ). B. 1. ( ). 2. ( )# 3. ( " " ). 4. ( ). 5. ( ). 6. prostatism ( ) ( ). 7. ( ) benzodiazepines chlordiazepoxide, fluazepam, nitrazepam, chlorazepate benzodiazepines diazepam ( ). 8. ( 1 ) ( )# 9. ( ) (parkinsonism) ( ) 10. phenothiazines ( ). 11. ( )# 12. (SSRIs)( 2 <130mmol/l ). 13. ( ) diphenydramine, chlorpheniramine, cyclizine, promethazine ( ). 續下頁 372 家庭醫學與基層醫療 第九期
4 STOPP # Beer's Criteria C. 1. diphenoxylate, loperamide or codeine phosphate ( ). 2. diphenoxylate, loperamide or codeine phosphate ( ) 3.prochlorperazine or metoclopramide (parkinsonism) ( ) 4. PPI 8 ( )# 5. ( ). D. 1. ( )# 2. (COPD) ( ). 3. ipratropium ( ). E. 1. histamine H2 receptor antagonist, PPI or misoprostol( ). 2. ( ) # 3. ( )# 4. ( 3 ) ( ) 5. warfarin ( ). 6. ( )# 7. ( 3 ) ( ). 8.colchicine allopurinol( ) (allopurinol ) F. 1. bladder antimuscarinic drugs ( ). 2. bladder antimuscarinic drugs ( ). 3. bladder antimuscarinic drugs ( ). 4. bladder antimuscarinic drugs prostatism ( ). 5. -blocker ( )# 6. -blocker 2 ( ). G. 1. glibenclamide or chlorpropamide ( ). 2. -blocker ( ) ( )# 3. ( )# 4. oestrogens progestogen( ). H. ( ) 1.benzodiazepines ( ). 續下頁 家庭醫學與基層醫療 第九期 373
5 STOPP # Beer's Criteria 2. ( )# 3. ( ). 4.>20mmHg( )# 5. ( ). I. 止痛藥物 1. morphine or fentanyl ( 2.WHO analgesic ladder ). 3. ( 2 ) ( )# 4.( ) ( ). J. 重複用藥 (ACEIs) ( )# 2-agonists estimated GFR <50ml/min. 資料來源 : 參考資料 Gallagher 2008 STOPP Beer's Criteria 715 STOPP Beer's Criteria 77 6 STOPP Beer's Criteria STOPP Beer's Criteria STOPP STOPP Beer's criteria STOPP Beer's Criteria # START 準則 START START START 57.9% statins ( ) (26%) warfarin( ) (9.5%) 374 家庭醫學與基層醫療 第九期
6 START A. 心血管系統 1. warfarin 2. warfarin aspirin 3. aspirin or clopidogrel mmhg 5. statin 6. (ACEIs) blocker B. 呼吸系統 1. 2-agonists (PO2<8.0kPa, PCO2 <6.5kPa) (PO2< 8.0kPa, PCO2> 6.5kPa) C. 中樞神經系統 1. L-DOPA (idiopathic Parkinson's disease, ) 2. D. 消化道系統 1. PPI 2. E. 骨骼肌肉系統 1. disease-modifying anti-rheumatic drug (DMARD) bisphosphonate 3. ( ) D F. 內分泌系統 1. metformin ( *) 2. ACEI angiotension receptor blocker(arb) overt dipstick proteinuria or microalbuminuria (>30 mg/24 h) serum biochemical renal impairment*. 3. ( ) aspirin 4. statin estimated GFR <50ml/min. 資料來源 : 參考資料 8 家庭醫學與基層醫療 第九期 375
7 ( ) (7.3%) D( ) (6%) 結論 參考資料 1. Juurlink DN, Mamdami M, Kopp A et al: Drug-drug interactions among elderly patients hospitalised for drug toxicity. JAMA 2003; 289: Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK: Prevalence of the Prescribing of Potentially Inappropriate Medications at Ambulatory Care Visits by Elderly Patients Covered by the Taiwanese National Health Insurance Program. Clinical Therapeutics 2009; 31: Goldberg RM, Mabee J, Chan L, Wong S: Drug-drug and drug-disease interactions in the emergency department: analysis of a high-risk population. Am J Emerg Med 1996; 14: Mangoni AA, Jackson SHD: Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003; 57: Fick DM, Cooper JW, WadeWet al.: Updating the beers criteria for potentially inappropriate medication use in older adults results of a US consensus panel of experts. Arch Intern Med 2003; 163: Gallagher P, O Mahony D: STOPP (Screening Tool of Older Persons Potentially Inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beer;s criteria. Age Aging 2008;37: G a l l a g h e r P, R y a n C, B y r n e S e t a l. : STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): consensus validation. Int J Clin Pharm Ther 2008; 46: Barry P, Gallagher P, Ryan C, O Mahony D: START (Screening Tool to Alert Doctors to Right Treatment). An evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: Akazawa M, Imai H, Igarashi A, Tsutani K: Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010; 8: McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997; 156: 家庭醫學與基層醫療 第九期
STOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationSTOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationSurvey of Potentially Inappropriate Prescription Using STOPP/START Criteria in Inha University Hospital
Korean J Fam Med. 2013;34:319-326 http://dx.doi.org/10.4082/kjfm.2013.34.5.319 Survey of Potentially Inappropriate Prescription Using STOPP/START Criteria in Inha University Hospital Original Article Sang-Jin
More informationScreening tools for elderly patients in primary care
Screening tools for elderly patients in primary care Cristín Ryan 1 Prof. Julia Kennedy 1 Dr. Denis O Mahony 2 Dr. Stephen Byrne 1 Co-Investigator: Dr. Paul Gallagher 2 1 Pharmaceutical Care Research Group,
More informationF A C U L T Y O F H E A L T H A N D M E D I C A L S C I E N C E S U N I V E R S I T Y O F C O P E N H A G E N A P P E N D I X
F A C U L T Y O F H E A L T H A N D M E D I C A L S C I E N C E S U N I V E R S I T Y O F C O P E N H A G E N A P P E N D I X 1 st June 2014 Academic advisor: Charlotte Vermehren Submitted: 1 st June 2014
More informationSTOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age
European Geriatric Medicine 1 (2010) 45 51 Pharmacology applied to geriatric medicine STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age D. O Mahony a,
More informationInappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria
Int J Clin Pharm (2012) 34:855 862 DOI 10.1007/s11096-012-9681-8 RESEARCH ARTICLE Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria Mohd Shahezwan Abd Wahab
More informationAll rights reserved. For Permissions, please
Age and Ageing 2008; 37: 673 679 doi: 10.1093/ageing/afn197 Published electronically 1 October 2008 C The Author 2008. Published by Oxford University Press on behalf of the British Geriatrics Society.
More informationIntelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork
Intelligent Polypharmacy Professor Colin P Bradley Department of General Practice University College Cork Polypharmacy No standard definition 2005 review the use of medications that are not clinically
More informationThere s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationTHE ADVANCED MEDICATION REVIEW
THE ADVANCED MEDICATION REVIEW PCNE WORKING SYMPOSIUM ON MEDICATION REVIEW 2009 WORKSHOP 3 Facilitator: Nina Griese n.griese@abda.aponet.de Aim of the workshop 2 To define an advanced medication review
More informationMedication safety in vulnerable patient groups - Elderly patients -
Woodennature/CC-BY-SA-3.0 http://theintelligence.de Medication safety in vulnerable patient groups - Elderly patients - 20th Congress of EAHP 25-27 March, 2015, Hamburg, Germany Dr. rer. nat. Beate Wickop
More informationSTOPP START Tool to Support Medication Review
STOPP START Tool to Support Medication Review Older people are known to have increased risk of adverse effects with medication due to age related alteration in pharmacokinetics and pharmacodynamics. This
More informationAdverse drug reaction (ADR) A specific reaction usually related to a medication s pharmacology
Differentiate between an adverse drug reaction (ADR) and an adverse drug event (ADE). Identify ADE risk factors in older adults. Apply strategies to ensure safe medication use in older adults. Utilize
More informationSTOPP START Toolkit Supporting Medication Review
STOPP START Toolkit Supporting Medication Review STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions. START: Screening Tool to Alert doctors to Right i.e. appropriate, indicated
More informationAppendix 3: Screening Tool of Older Persons Prescriptions (STOPP) version 2.
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 By Denis O'Mahony, David O'Sullivan, Stephen Byrne, Marie Noelle O'Connor, Cristin Ryan and Paul Gallagher Age
More informationDisclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives
Use caution in the elderly: review of safe and effective medication use in older patients Disclosures I have no disclosures or conflicts of interest related to this presentation John T. Holmes, PharmD,
More informationAppropriateness of prescribing in older patients
Appropriateness of prescribing in older patients Which tools should be used? Anne Spinewine MPharm, MSc, PhD Université catholique de Louvain, Belgium Louvain Drug Research Institute and CHU Mont-Godinne
More informationPotentially Inappropriate Medications in Elderly Haemodialysis Patients Using the STOPP Criteria. Krystina Parker, Willy Aasebø & Knut Stavem
Potentially Inappropriate Medications in Elderly Haemodialysis Patients Using the STOPP Criteria Krystina Parker, Willy Aasebø & Knut Stavem Drugs - Real World Outcomes ISSN 2199-1154 Drugs - Real World
More informationPitfalls in Pharmacotherapy of Geriatrics
Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD) Case Study An 85 year old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic
More informationThe PROMPT criteria: Development and validation of prescribing indicators in middle-aged adults
The PROMPT criteria: Development and validation of prescribing indicators in middle-aged adults Dr. Janine Cooper, Professor Carmel Hughes, Dr. Cristín Ryan, Professor Susan Smith, Dr. Emma Wallace, Dr.
More informationA2. Any drug prescribed beyond the recommended duration, where treatment duration is well defined.
Appendix 1: STOPP/START criteria version 2 applied to the TRUST dataset Physiological system Criteria (The relevant () criteria for each participant were applied to the dataset and recorded in Microsoft
More informationNational Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX
National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie PRESCRIBING IN THE ELDERLY INTRODUCTION According to the most recent census
More informationDrug-Drug Interactions 台大醫院藥劑部 林美淑藥師 / 副主任
Drug-Drug Interactions 台大醫院藥劑部 林美淑藥師 / 副主任 Limitations of clinical trials Short study period Small sample size Control environments, e.g. simple regimen DDIs are difficult to find Definition of drug-drug
More informationPrescribing and Pharmacokinetic Considerations in the Elderly
Prescribing and Pharmacokinetic Considerations in the Elderly Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics College of Pharmacy The University of New Mexico OBJECTIVES
More informationConflict of interest declaration and sources of funding
Potentially Inappropriate Prescribing immediately prior to Long-Term Care admission (PIP in LTC): Validation of tools for their future use across Ontario Bruyère CLRI Webinar March 24 th, 2016 and Bruyère
More informationCompleted audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia
Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia Victor M. Aziz, Natalie Hill, Sugandha Kumar BJPsych Bulletin (08) 4,
More information家庭醫業 流行病學 臨床症狀 蘇子華 葉慶輝 家庭醫學與基層醫療第二十四卷第九期. 1 國軍左營總醫院家庭醫學科住院醫師 2 國軍左營總醫院家庭醫學科主任關鍵詞 :liver hemangioma, hepatic cavernous hemangioma,
蘇子華 1 葉慶輝 2 前言 4 8 3.5 流行病學 1.5~2 0.4% 7.3% 1 國軍左營總醫院家庭醫學科住院醫師 2 國軍左營總醫院家庭醫學科主任關鍵詞 :liver hemangioma, hepatic cavernous hemangioma, focal liver lesion, ultrasound 30-50 6 () 1 4 20 4-6 : 1 臨床症狀 331 1.
More informationUse caution in the elderly: review of safe and effective medication use in older patients
Use caution in the elderly: review of safe and effective medication use in older patients John T. Holmes, PharmD, BCPS Assistant Professor of Family Medicine and Pharmacy Practice In support of improving
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More informationAvoid Coadministration of PPI & Clopidogrel (Plavix)? To be or not to be? That is the question! 黃以信 Yi-Shin Huang, MD, FACG 台北榮民總醫院胃腸科醫師國立陽明大學醫學院教授
Avoid Coadministration of PPI & Clopidogrel (Plavix)? To be or not to be? That is the question! 黃以信 Yi-Shin Huang, MD, FACG 台北榮民總醫院胃腸科醫師國立陽明大學醫學院教授 A story of drug interaction: PPI vs. clopidogrel GI meets
More informationInappropriate Medication Use in the Elderly
Inappropriate Medication Use in the Elderly Amanda Ilenin, Pharm.D. OhioHealth Dublin Methodist Hospital & OhioHealth Grady Memorial Hospital Kristian Navickas, Pharm.D. OhioHealth McConnell Heart Health
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More information2014 年推薦期刊使用情形 - 系所推薦
2014 年推薦期刊使用情形 - 系所推薦 說明 : (1) 2014 點選 從醫分館電子資源查詢系統之點選使用次數 (2) 2014 下載量 在本校有效網域之全文下載篇數 (NA 表出版社主機未提供或未能取得 ) 單位 期刊名 ISSN (p) 期刊代理商 / 出版商 2014 點選 2014 下載量 職治系 Adapted Physical Activity Quarterly: APAQ 0736-5829
More information乳癌化療指引. Breast Cancer
乳癌化療指引 103 年 12 月第五版 99-102 年, 第一至四版 注意事項 : 本院癌症團隊基於實證醫學制定此化學治療指引 : 本院癌症團隊基於實證醫學制定此化學治療指引, 實證醫學之結論源自臨床詴驗, 實證醫學之結論源自臨床詴驗, 惟參與臨床詴驗之研究對象多以 70 歲以下之病人為主, 故建議 70 歲以上病人接受治療時, 應依據病人實際臨床狀況進行抗癌藥物劑量之調整! 健保藥品給付限制註記說明
More informationStrategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS
Strategies to Decrease Medication Errors in Elderly Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS Road Map..Outline 1. Introduction A. Definitions B. Geriatrics: High risk population C.
More informationUpdate to 2014 document
Update to 2014 document OFFICIAL NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy Finance Publications
More informationPurdue e-pubs. Purdue University. Engels Nnamdi Obi Purdue University. Fall 2013
Purdue University Purdue e-pubs Open Access Dissertations Theses and Dissertations Fall 2013 Patients' Perceptions of Provider Communication, Provider Knowledge and Provider Competence and Associations
More informationA review of screening tools used for the assessment of appropriateness of prescription s among elderly patients
Review article ISSN 2321-0125 www.jpbs-online.com A review of screening tools used for the assessment of appropriateness of prescription s among elderly patients Mandavi Kashyap*, Muhammad Zahid Iqbal
More informationPotentially inappropriate prescribing and cost outcomes for older people: a national population study
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2010.03628.x Potentially inappropriate prescribing and cost outcomes for older people: a national population study Caitriona Cahir, 1 Tom
More informationSTOPP: Screening Tool of Older People s potentially inappropriate Prescriptions 1.
40 STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions 1. Prescriptions that are potentially inappropriate in persons aged 65 years of age Page Introduction 4 To print a copy
More informationStronger together - optimizing pharmacotherapy on geriatric wards?
Stronger together - optimizing pharmacotherapy on geriatric wards? Clinicamp FOD 27/4/2018 Dr. Jean-Claude Lemper ( Geriater UZ Brussel) Apr. Julie Hias (ziekenhuisapotheker UZ Leuven) Project College
More informationThe Role of Pharmacists achieving international best practice standards and realising key opportunities.
The Role of Pharmacists achieving international best practice standards and realising key opportunities. Dr. Stephen Byrne Senior Lecturer in Clinical Pharmacy & Director of the MSc in Clinical Pharmacy
More informationRebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.
Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L. Murphy Division Clinical Assistant Professors, University of Texas/UTHSCSA
More information乳癌化療指引. 104 年 12 月第六版 年,1 st - 5 th 版
乳癌化療指引 104 年 12 月第六版 99-103 年,1 st - 5 th 版 注意事項 : 本院癌症團隊基於實證醫學制定此化學治療指引 : 本院癌症團隊基於實證醫學制定此化學治療指引, 實證醫學之結論源自臨床試驗, 實證醫學之結論源自臨床試驗, 惟參與臨床試驗之研究對象多以 70 歲以下之病人為主, 故建議 70 歲以上病人接受治療時, 應依據病人實際臨床狀況進行抗癌藥物劑量之調整! 健保藥品給付限制註記說明
More informationDe-prescribing in Older Adults. Wael Hamade, MD, FAAFP 04/08/2016
De-prescribing in Older Adults Wael Hamade, MD, FAAFP 04/08/2016 DISCLOSURES None of the faculty, planners, speakers, providers nor CME committee has any relevant financial relationships with commercial
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Specific needs of patients with chronic disease Drug Nutrient interactions R. Witkamp (NL) Drug Nutrient interactions Prof dr. Renger Witkamp Nutrition and Pharmacology @rengerwitkamp
More informationCHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS
CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS 1. The following is an accurate description of the aging population: A. The number of older adults will reach 17 million in 2030 B. The ratio of women to
More informationA Pilot High-volume Low-cost Hospital-community Partnership Programme in the Management of Orthopaedic Patients With Chronic Pain Syndrome
A Pilot High-volume Low-cost Hospital-community Partnership Programme in the Management of Orthopaedic Patients With Chronic Pain Syndrome Cheung KK 1 Chan PH 1 Chow YY 1 Hung ATF 2 Ho JPS 2 Tse A 1 Chan
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More information腹部按摩於改善脊髓損傷者神經性腸道功能障礙之 成效 系統性文獻回顧
90 Abdominal Massage for Neurogenic Bowel Dysfunction 腹部按摩於改善脊髓損傷者神經性腸道功能障礙之 成效 系統性文獻回顧 1 2 3 * 1 2 3 摘要 背景 目的 方法 結果 結論 / 實務應用 6 2016 6 Downs Black 8 4 2 13 25 關鍵詞 : 前言 spinal cord injury 12,000 80.7%40.6%
More informationInterdisciplinary detection of potential drug related problems in older people
Interdisciplinary detection of potential drug related problems in older people Prof. dr. Mirko Petrovic Department of Internal Medicine, Ghent University Department of Geriatrics, Ghent University Hospital,
More informationPhysical and Sensory Changes in the Older Adult: Considerations for Medication Management
Physical and Sensory Changes in the Older Adult: Considerations for Medication Management Amber M. Hutchison, PharmD, BCPS Assistant Clinical Professor Auburn University Harrison School of Pharmacy Disclosure/Conflict
More informationThe 2nd ITCN, Pain and Headache Session (5/19) 10
http://www.taiwanheadache.com.tw/ M ~t, IWr OncoMhTpadm ( fbmlec ) The 2nd ITCN, Pain and Headache Session (5/19) 10 Acute Migraine Treatment Guidelines Update Symposium 11 18 th Congress of the International
More informationCo-morbidities of patients with knee osteoarthritis
O R I G I N A L A R T I C L E KW Chan HY Ngai KK Ip KH Lam WW Lai 陳國維倪浩然葉傑權林敬熹黎偉華 Co-morbidities of patients with knee osteoarthritis CME Objectives To study the co-morbidities of general practice patients
More informationUpdate on Infertility Research in Taiwan 林永明 國立成功大學醫學系泌尿學科
Update on Infertility Research in Taiwan 林永明 國立成功大學醫學系泌尿學科 民 65.07 目前國內研究男性不孕症機搆 台大醫院泌尿部 台北榮總泌尿科 三軍總醫院泌尿科 林口長庚醫院泌尿科 北醫附設泌尿科 輔仁大學 成大醫院泌尿部 / 婦產部 中研院生醫所 台北市聯合醫院仁愛院區 資料收集方式 男性不孕症研究小組成員 國內其他非泌尿科研究室研究男性不孕症 NCBI
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More information物理治療 館藏資源示意圖 館藏介紹 一 學科範圍
物理治療 館藏資源示意圖 楊盈慈 技術服務股 一 學科範圍 物理治療是利用聲 電 水 冷 熱 力 光等物理因子來預防 鑑別 評估 治療病 患 並改善機能損傷及功能障礙 為結合科學與藝術的醫療專業 物理治療師透過對病患身 體功能的詳盡檢查 治療與教育 以察覺與評估身體功能的狀況 進而加以預防 矯正 減 輕與限制肢體的障礙 身體功能不良 動作功能失調的範圍與程度 以及因為外傷 疾病或 其他身心層面所造成的疼痛問題
More informationUncertainty of Measurement Application to Laboratory Medicine 鏡檢組 蔡雅雯 2014/09/09
Uncertainty of Measurement Application to Laboratory Medicine 鏡檢組 蔡雅雯 2014/09/09 Objectives Definitions Methodology Equation of Measurement Uncertainty Measurement Uncertainty Goal Examples Uncertainty
More information研究專長 1. 超音波應用 2. 組織工程 3. 臨床牙科研究 教學榮譽獎項或競賽優勝事蹟 1. 於 2010 中區技專院校產學合作論壇暨研發成果展發表 骨質密度檢測參考輔具 榮獲特優 2. 於 2010 中區技專院校產學合作論壇暨研發成果展發表 長效皮膚標記染料 榮獲優等
研究專長 1. 超音波應用 2. 組織工程 3. 臨床牙科研究 教學榮譽獎項或競賽優勝事蹟 1. 於 2010 中區技專院校產學合作論壇暨研發成果展發表 骨質密度檢測參考輔具 榮獲特優 2. 於 2010 中區技專院校產學合作論壇暨研發成果展發表 長效皮膚標記染料 榮獲優等 3. 於 2010 第五屆國際醫學影像暨放射科學研討會, 壁報論文 以輔具配和牙根尖片攝影進行齒槽骨厚評估, 獲得大會 第二名
More information義大醫院健診部部長 許家彰 學經歷 專長肝膽胃腸科疾病之診斷與治療 診斷性與治療性之經內視鏡膽胰管攝影術 胃腸道狹窄之經內視鏡氣球擴張術 胃腸道息肉與腫瘤之內視鏡切除術
義大醫院健診部部長 許家彰 學經歷 義大醫院健診部部長中山醫科大學醫學系畢義大醫院肝膽胃腸科主治醫師高雄長庚胃腸肝膽科主治醫師台灣消化系內視鏡醫學會指導醫師中華民國超音波學會指導醫師教育部部定助理教授 專長肝膽胃腸科疾病之診斷與治療 診斷性與治療性之經內視鏡膽胰管攝影術 胃腸道狹窄之經內視鏡氣球擴張術 胃腸道息肉與腫瘤之內視鏡切除術 期刊論文 1. Hsu CC, Chen JJ, Changchien
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationA STUDY THE PSYCHOLOGICAL AND PHYSIOLOGICAL INFLUENCES OF THE ELDERLY IN TERMS OF FITNESS EQUIPMENT OF THE TENDON- MOTIONS
A STUDY THE PSYCHOLOGICAL AND PHYSIOLOGICAL INFLUENCES OF THE ELDERLY IN TERMS OF FITNESS EQUIPMENT OF THE TENDON- MOTIONS Ruoh-Pyng Wu 1, Ping-Hong Kuo 1 and Wei-Hsing Peng 1 1 The Industrial Design Department
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More informationEmergency Geriatrics. Essentials in Caring for Older Patients CCFP(EM) FCFP
Emergency Geriatrics 101 Essentials in Caring for Older Patients Don Melady BA MD MScCH(c) Don Melady BA MD MScCH(c) CCFP(EM) FCFP Ten Things I know about Old People in the ED Learning Objectives At the
More informationRationalizing Medications. Tan Jianming Senior Pharmacist KTPH
Rationalizing Medications Tan Jianming Senior Pharmacist KTPH + Older patients are more likely to: 2 Have multiple co-morbid diseases Have age-related physiological changes that result in a reduced tolerance
More information陳俊榮醫師 講師學經歷 中山醫學大學牙醫學系畢業高雄醫學大學牙醫學研究所碩士美國哈佛大學口腔植體學研究員台灣牙周病醫學會專科醫師中華民國口腔植體學會專科醫師奇美醫學中心牙周病科主治醫師. ITI Fellow
陳俊榮醫師 講師學經歷 中山醫學大學牙醫學系畢業高雄醫學大學牙醫學研究所碩士美國哈佛大學口腔植體學研究員台灣牙周病醫學會專科醫師中華民國口腔植體學會專科醫師奇美醫學中心牙周病科主治醫師 ITI Fellow Chung Shan Medical University, DDS Kaohsiung Medical University, MS Periodontal specialist, Taiwan
More informationDeveloping Valid Prescribing Quality Indicators Petra Denig
Developing Valid Prescribing Quality Indicators Petra Denig Clinical Pharmacology Department, University Medical Center Groningen, University Groningen, The Netherlands 2 Disclosure Funding sources: University
More informationENGAGING PATIENTS TO SELF-EMPOWERMENT BY USE OF OPAS IN PYNEH PRC 門診預約系統打開病人參與及賦能的實踐
ENGAGING PATIENTS TO SELF-EMPOWERMENT BY USE OF OPAS IN PYNEH PRC 門診預約系統打開病人參與及賦能的實踐 東區醫院 社區及病人資源部 2 1/1995 9/1995 3/2002 Development Timeline of OPAS in PYNEH Enhance with more disease groups for Cancer
More informationManaging medicines in older people. Jane Noble and Caroline Ralph
Managing medicines in older people Jane Noble and Caroline Ralph Where? Community Hospital Care Home What? Prescribing Dispensing Administering Case 1 84 year old lady Admitted with reduced mobility Recurrent
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationPharmaceutical Care for Geriatrics
Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING
More informationPolypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit
INTERNATIONAL JOURNAL of BIOMEDICAL SCIENCE ORIGINAL ARTICLE Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit Joanna Ulley 1, Sakila Sickander 2, Ahmed H.
More informationRoyal College of Surgeons in Ireland Barbara Clyne Royal College of Surgeons in Ireland
Royal College of Surgeons in Ireland e-publications@rcsi General Practice Articles Department of General Practice 2-6-2016 Sustained effectiveness of a multifaceted intervention to reduce potentially inappropriate
More information周邊神經與復健研究室 學歷 學 校 系 ( 所 ) 學 位 國立成功大學 生物醫學工程學系 博士 國立成功大學 物理治療學系 碩士 國立成功大學 物理治療學系 學士
周邊神經與復健研究室 更新日期 :2019.01.30 主持人 : 蔡依蓉助理研究員 聯絡方式聯絡地址 : 高雄市燕巢區義大路六號育成研究實驗大樓 7 樓 10719 室聯絡電話 :07-6151100 分機 5105 E-mail:ed108805@edah.org.tw 學歷 學 校 系 ( 所 ) 學 位 國立成功大學 生物醫學工程學系 博士 國立成功大學 物理治療學系 碩士 國立成功大學 物理治療學系
More informationA Step Forward: Promoting Independence through Falls Prevention
A Step Forward: Promoting Independence through Falls Prevention 2014 Geriatric Update Meharry Consortium Geriatric Education Center A Step Forward: Promoting Independence through Falls Prevention Moderator:
More informationPolypharmacy: Guidance for Prescribing in Frail Adults
Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years
More informationA Sustainable Hospitalcommunity. Programme for Orthopaedic Patients with Chronic Pain Syndrome
A Sustainable Hospitalcommunity Partnership Programme for Orthopaedic Patients with Chronic Pain Syndrome Cheung KK 1 Chan PH 1 Chow YY 1 Hung ATF 2 Ho JPS 2 Tse A 1 Chan I 1 Ip A 1 Wong C 1 Fung C 1 Kwok
More informationSpondylodiscitis and Infective Endocarditis Caused by Streptococcus bovis in a Patient with Colon Cancer
台灣老誌 Case Report Spondylodiscitis and Infective Endocarditis caused by 第 4 卷第 4 期 Spondylodiscitis and Infective Endocarditis Caused by Cheng-Wei Wang, Yu-Ming Jian, Rong-Sen Yang Abstract Musculoskeletal
More informationPolypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP
Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter
More informationSafe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science
Safe Medication Use in the Older Adult Holly Divine, PharmD, CGP, CDE Associate Professor University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science Objectives Know the principles
More informationWhat is all about cancer and how to face he (or she)? 慈濟綜合醫院 高瑞和
What is all about cancer and how to face he (or she)? 慈濟綜合醫院 高瑞和 Agenda 1. What is cancer? 2. How to diagnose and treat it? 3. How to develop new cancer therapy? 4. Is cancer preventable? 5. How to survive
More informationPolypharmacy and Elders. Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging
Polypharmacy and Elders Leslie Baker, Pharm. D., RPh, CGP Sanford Center for Aging Prescription Medication Use In Elders 1 13% of the US population is age 65+ Age 65 years 13% Age 65+ account for 34% of
More informationAlleviating Cancer Pain Toward Better Quality of Life
Alleviating Cancer Pain Toward Better Quality of Life 林至芃醫師 台大醫院麻醉部疼痛科科主任台大醫院麻醉部暨腫瘤醫學部合聘主治醫師台大醫學院醫學系臨床助理教授台灣疼痛醫學會秘書長 82 y/o male Newly diagnosed PC Initial presentation Back pain Shoulder pain Rapid progressed
More informationThe STOPP/START Criteria: International Synthesis and Local Contextualization
The STOPP/START Criteria: International Synthesis and Local Contextualization Presented November 21, 2014 to TVN MindMerge TVN Improving care for the frail elderly Barbara Hill-Taylor IMPART, College of
More informationASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS
ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS O. Dalleur 1,4, B. Boland 2,3, A. Spinewine 4-5 1 Pharmacy and 2 Geriatric Medicine, St-Luc university Hospital, 3 Institute of
More informationFamily Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD
Family Medicine for English language students of Medical University of Lodz Seminar 12 Elderly care Przemysław Kardas MD PhD Europe is facing demographic challenge 2014 2080 2 3 Old vs young: major differences
More informationClinical Nursing Application of Tidal Peritoneal Dialysis
Clinical Nursing Application of Tidal Peritoneal Dialysis 高雄長庚醫院腹膜透析室 郭麗雀 PD catheter implantation This 76 years old male has history of ESRD and initiated CAPD since 2005 PD catheter was implanted on
More informationAssessment of Drug Therapy in Geriatric Patients Using Beer s Criteria
Original Article Assessment of Drug Therapy in Geriatric Patients Using Beer s Criteria RJ Lihite *, M Lahkar **, S Roy * Abstract Aim: Inappropriate medication use (IMU) in the elderly population has
More informationMake EBM Individualized and Smarter
Make EBM Individualized and Smarter Hao-min Cheng, M.D., PhD. Department of Medical Education, Taipei Veterans General Hospital Division of Cardiology, Taipei Veterans General Hospital Faculty of Medicine,
More informationUniversity of Hawaii Center on Aging
University of Hawaii Center on Aging. Supported in part by a cooperative agreement No. 90AL0011-01-00 from the Administration on Aging, Administration for Community Living, U.S. Department of Health and
More information頁數 : 2 of 7 附錄及 MDL 匯整表 : Digitoxin 心臟血管類用藥 100 Meperidine 局部麻醉類 10 Dipyridamole 心臟血管類用藥 10 Chloramphenicol 抗生素類 10 Nylidrin 心臟血管類用藥 10 Econazole 抗生素類
頁數 : 1 of 7 以下測試之樣品係由申請廠商所提供及確認 : 產品名稱 : 能量飲 申請廠商 : 產品型號 / 批號 : --- 樣品狀態 : 請參考報告末頁樣品照片 製造日期 : 有效期限 : 收樣日期 : --- --- 2017 年 03 月 01 日 測試日期 : 2017 年 03 月 01 日 ~ 2017 年 03 月 15 日 委託 : 測試方法 : 312 項常見西藥成份分析
More informationAs a geriatrician: I have cured more diseases by stopping medications than by starting them 10/26/2018
: A 10 Step Approach to Polypharmacy Texas Health Resources Geriatrics Symposium November 3, 2018 Amit Shah, MD, FACP, AGSF Associate Dean for Faculty Affairs, Mayo Clinic School of Medicine Assistant
More informationMedication Debridement: A 10 Step Approach to Polypharmacy
Medication Debridement: A 10 Step Approach to Polypharmacy Texas Health Resources Geriatrics Symposium November 3, 2018 Amit Shah, MD, FACP, AGSF Associate Dean for Faculty Affairs, Mayo Clinic School
More informationAging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace
Aging and Geriatric Assessment Page 1 Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace I. Aging A. Demographics Age 65+ population 3.1 million 1900 31.2 million
More informationGeri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful
More informationLet it go! Rationalising medicines for patients with life limiting illness
Let it go! Rationalising medicines for patients with life limiting illness Inga Andrew Senior Clinical Pharmacist Northumbria Healthcare Trust E-mail: inga_andrew@northumbria-healthcare.nhs.uk Welcome
More informationMajority of drug-related problems identified during medication review are not associated with STOPP/START criteria
Eur J Clin Pharmacol (2015) 71:1255 1262 DOI 10.1007/s00228-015-1908-x PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Majority of drug-related problems identified during medication review are not associated with
More information